A detailed history of Fort, L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fort, L.P. holds 3,374 shares of GILD stock, worth $318,539. This represents 0.73% of its overall portfolio holdings.

Number of Shares
3,374
Previous 3,420 1.35%
Holding current value
$318,539
Previous $234,000 20.51%
% of portfolio
0.73%
Previous 0.61%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$66.59 - $83.99 $3,063 - $3,863
-46 Reduced 1.35%
3,374 $282,000
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $22,039 - $25,435
349 Added 11.36%
3,420 $234,000
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $27,773 - $33,868
-388 Reduced 11.22%
3,071 $224,000
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $13,235 - $14,439
-179 Reduced 4.92%
3,459 $259,000
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $47,658 - $54,360
-627 Reduced 14.7%
3,638 $280,000
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $157,867 - $179,859
-2,042 Reduced 32.38%
4,265 $353,000
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $126,696 - $181,892
-2,033 Reduced 24.38%
6,307 $541,000
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $265,548 - $303,324
-4,460 Reduced 34.84%
8,340 $514,000
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $91,082 - $102,585
-1,578 Reduced 10.98%
12,800 $791,000
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $88,849 - $111,337
1,534 Added 11.94%
14,378 $855,000
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $155,647 - $176,662
2,399 Added 22.97%
12,844 $933,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $122,112 - $131,746
-1,804 Reduced 14.73%
10,445 $730,000
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $311,193 - $340,023
-4,903 Reduced 28.59%
12,249 $843,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $2,040 - $2,327
-34 Reduced 0.2%
17,152 $1.11 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $62,088 - $70,746
1,096 Added 6.81%
17,186 $1 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $88,182 - $110,873
1,420 Added 9.68%
16,090 $1.02 Million
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $1.9 Million - $2.21 Million
-26,317 Reduced 64.21%
14,670 $1.13 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $12,588 - $16,124
201 Added 0.49%
40,987 $3.06 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $157,500 - $173,245
2,556 Added 6.69%
40,786 $2.65 Million
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $217,847 - $240,465
3,485 Added 10.03%
38,230 $2.42 Million
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $808,145 - $906,241
-13,062 Reduced 27.32%
34,745 $2.35 Million
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $2.82 Million - $3.16 Million
-45,140 Reduced 48.57%
47,807 $3.11 Million
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $4.22 Million - $5.5 Million
-69,660 Reduced 42.84%
92,947 $5.81 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $9.04 Million - $10 Million
-126,846 Reduced 43.82%
162,607 $12.6 Million
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $773,045 - $901,727
-11,915 Reduced 3.95%
289,453 $20.5 Million
Q1 2018

May 09, 2018

BUY
$72.84 - $88.8 $1.7 Million - $2.07 Million
23,333 Added 8.39%
301,368 $22.7 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $2.37 Million - $2.78 Million
33,322 Added 13.62%
278,035 $19.9 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $17.6 Million - $20.9 Million
244,713
244,713 $19.8 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Fort, L.P. Portfolio

Follow Fort, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.